Response-Adapted Treatment with Nivolumab and Brentuximab Vedotin (BV) in Children, Adolescents and Young Adults (CAYA) with Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL): CheckMate 744 Subgroup Analyses
Year: 2019
Type: article
Authors: Kara M. Kelly, Stephen Daw, Christine Mauz-Körholz, Maurizio Mascarin, Gerard Michel, Stacy Cooper, Auke Beishuizen, Kasey J. Leger, Alberto Garaventa, Salvatore Buffardi, Laurence Brugières, Paul Harker-Murray, Peter D. Cole, Richard A. Drachtman, Thomas Manley, Stephen Francis, Mariana Sacchi, Thierry Leblanc
Institutions: Roswell Park Comprehensive Cancer Center, University College Hospital, Justus-Liebig-Universität Gießen, Martin Luther University Halle-Wittenberg, Hôpital de la Timone, Johns Hopkins Hospital, Princess Máxima Center, Seattle Children's Hospital, Istituto Giannina Gaslini, Santobono Children's Hospital, Institut Gustave Roussy, Children's Hospital of Wisconsin, Rutgers Cancer Institute, Seagen (United States), Bristol-Myers Squibb (United States), Assistance Publique – Hôpitaux de Paris, Hôpital Robert-Debré
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2970547423